![PDF] Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. | Semantic Scholar PDF] Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4f9582669148cbf9cf6d6ab28497bdbda8615c3/3-Table1-1.png)
PDF] Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. | Semantic Scholar
![Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis](https://www.mdpi.com/cancers/cancers-12-02180/article_deploy/html/images/cancers-12-02180-g001.png)
Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
![When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/01/table1.png)
When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK
![Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-021-00372-x/MediaObjects/41391_2021_372_Fig1_HTML.png)
Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases
![Serum prostate specifi c antigen (PSA) levels versus leuprolide schedule. | Download Scientific Diagram Serum prostate specifi c antigen (PSA) levels versus leuprolide schedule. | Download Scientific Diagram](https://www.researchgate.net/publication/341080345/figure/tbl2/AS:886429773225987@1588352735665/Serum-prostate-specifi-c-antigen-PSA-levels-versus-leuprolide-schedule.png)
Serum prostate specifi c antigen (PSA) levels versus leuprolide schedule. | Download Scientific Diagram
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t2.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
![Table 1 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar Table 1 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aed22c0affb1decf9e7953f12f3a9fb0849553/20-Table1-1.png)
Table 1 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar
![Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience | Radiation Oncology | Full Text Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-021-01808-3/MediaObjects/13014_2021_1808_Fig2_HTML.png)